288 related articles for article (PubMed ID: 23118010)
1. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
[TBL] [Abstract][Full Text] [Related]
2. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
[TBL] [Abstract][Full Text] [Related]
4. Methionine Antagonizes
Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
[No Abstract] [Full Text] [Related]
5. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
6. Deletion of
Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
[TBL] [Abstract][Full Text] [Related]
7. The aminosalicylate - folate connection.
London RE
Drug Metab Rev; 2024 Feb; 56(1):80-96. PubMed ID: 38230664
[TBL] [Abstract][Full Text] [Related]
8. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
Wang X; Yang S; Gu J; Deng J
Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the promoter region of methionine transporter gene
Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
12. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
[TBL] [Abstract][Full Text] [Related]
13. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
15. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand.
Dokladda K; Billamas P; Jaitrong S; Suwanakitti N; Phornsiricharoenphant W; Viratyosin W; Prammananan T
World J Microbiol Biotechnol; 2023 Dec; 40(1):32. PubMed ID: 38057660
[TBL] [Abstract][Full Text] [Related]
17. The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives.
Agoni C; Ramharack P; Salifu EY; Soliman MES
Protein J; 2020 Apr; 39(2):106-117. PubMed ID: 32086691
[TBL] [Abstract][Full Text] [Related]
18. Folate pathway disruption leads to critical disruption of methionine derivatives in Mycobacterium tuberculosis.
Nixon MR; Saionz KW; Koo MS; Szymonifka MJ; Jung H; Roberts JP; Nandakumar M; Kumar A; Liao R; Rustad T; Sacchettini JC; Rhee KY; Freundlich JS; Sherman DR
Chem Biol; 2014 Jul; 21(7):819-30. PubMed ID: 24954008
[TBL] [Abstract][Full Text] [Related]
19. Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum.
Wang P; Wang Q; Aspinall TV; Sims PF; Hyde JE
Mol Microbiol; 2004 Mar; 51(5):1425-38. PubMed ID: 14982635
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).
Hegde PV; Howe MD; Zimmerman MD; Boshoff HIM; Sharma S; Remache B; Jia Z; Pan Y; Baughn AD; Dartois V; Aldrich CC
Eur J Med Chem; 2022 Mar; 232():114201. PubMed ID: 35219151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
